戻る Agenda
Is It Time to Change the Content and Format of Labeling?
Session Chair(s)
Ingrid Bryzinski
Senior Director, Global Labeling
AbbVie, United States
How do you make labeling useful to patients and healthcare providers (HCPs) using the latest technology? This interactive panel session will include an FDA speaker, a patient representative, and an industry speaker, who will each provide insights into ensuring product labeling is useful and informative.
Learning Objective : Identify new requirements for labeling content and format; Discuss opportunities for future enhancements to labeling to improve utility for patients and healthcare providers.
Speaker(s)
Updating Prescription Drug and Biological Product Labeling
Eric Brodsky, MD
FDA, United States
Associate Director, Labeling Development Team, Office of New Drugs, CDER
Industry Perspective
Kathy A. Clark, BSN, RN
Eli Lilly and Company, United States
Director, Global Regulatory Affairs, US Advertising and Promotion
Patient Perspective
Jeff Allen, PHD
Friends of Cancer Research, United States
President and Chief Executive Officer